Psoriasis Submissions In The Bag, J&J Advances Icotrokinra Into Phase III For Ulcerative Colitis

Bausch announced topline results from its Phase II study of amiselimod in ulcerative colitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immunological

More from Therapy Areas